WallStreetZenWallStreetZen

NYSE: ELV
Elevance Health Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Elevance Health revenue was $177.01B for the trailing 12 months ending Dec 31, 2024, with 1.7% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $45.4B, up 0.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ELV annual revenue was $177.0B, with 3.3% growth year-over-year.

ELV past revenue growth

How has ELV's revenue growth performed historically?

Company
3.31%
Industry
9.74%
Market
20.68%
ELV's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ELV's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ELV's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ELV revenue history

Current Revenue
$177.0B
Current Earnings
$6.0B
Current Profit Margin
3.4%
ELV's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when ELV announces revenue.

ELV Revenue History By Year

ELV Yearly RevenueELV RevenueELV ChangeELV Revenue Growth
2024-12-31$177.01B$5.67B+3.31%
2023-12-31$171.34B$14.75B+9.42%
2022-12-31$156.60B$17.96B+12.95%
2021-12-31$138.64B$16.77B+13.76%
2020-12-31$121.87B$17.65B+16.94%
2019-12-31$104.21B$12.11B+13.15%
2018-12-31$92.11B$2.07B+2.29%
2017-12-31$90.04B$5.18B+6.10%
2016-12-31$84.86B$5.71B+7.21%
2015-12-31$79.16B$5.28B+7.15%
2014-12-31$73.87B$2.85B+4.01%
2013-12-31$71.02B$9.53B+15.49%
2012-12-31$61.50B$786.50M+1.30%
2011-12-31$60.71B$2.01B+3.43%
2010-12-31$58.70B-$6.24B-9.61%
2009-12-31$64.94B$3.69B+6.02%
2008-12-31$61.25B$83.20M+0.14%
2007-12-31$61.17B$4.11B+7.20%
2006-12-31$57.06B$12.44B+27.89%
2005-12-31$44.61B$23.91B+115.44%
2004-12-31$20.71B$3.93B+23.40%
2003-12-31$16.78B$3.49B+26.25%
2002-12-31$13.29B$2.85B+27.26%
2001-12-31$10.44B$1.67B+19.08%
2000-12-31$8.77B$2.50B+39.89%
1999-12-31$6.27B$587.70M+10.34%
1998-12-31$5.68BN/AN/A

1 of 2

Elevance Health Revenue FAQ

What was ELV's revenue last quarter?

On Invalid Date, Elevance Health (NYSE: ELV) reported Q4 2024 revenue of $45.44 billion up 6.55% year over year. In the same quarter last year, Elevance Health's revenue was $42.65 billion.

What was Elevance Health's revenue in 2024?

Elevance Health's annual revenue for the twelve months ending Dec 31, 2024 was $177.01 billion, a 3.31% increase year over year.

How much does Elevance Health make in a day?

Based on Elevance Health annual revenue for the past five years, ELV makes an average of $419,425,753.42 per day.

What was Elevance Health's annual revenue growth in the past year?

As of Q2 2025, Elevance Health's revenue has grown 3.31% year over year. This is 6.43 percentage points lower than the US Healthcare Plans industry revenue growth rate of 9.74%. Elevance Health's revenue in the past year totaled $177.01 billion.

How much does Elevance Health make in a year?

Elevance Health's revenue by year for the past five years is:
  • Elevance Health's revenue for the twelve months ending Dec 31, 2024 was $177.01 billion, a 3.31% increase year over year.
  • Elevance Health's annual revenue for Dec 31, 2023 was $171.34 billion, a 9.42% increase from 2022.
  • Elevance Health's annual revenue for 2022 was $156.60 billion, a 12.95% increase from 2021.
  • Elevance Health's annual revenue for 2021 was $138.64 billion, a 13.76% increase from 2020.
  • Elevance Health's annual revenue for 2020 was $121.87 billion, a 16.94% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.